NCT02517918 2025-06-08
METZOLIMOS
Institut Bergonié
Phase 1 Completed
Clinical Trials
10 trialsNCT01671774 2024-11-14
PILOT
Astellas Pharma Inc
Phase 1 Completed
NCT00885326 2023-04-10
N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium
Phase 1 Completed
NCT00424983 2020-12-21
Study of Zoledronic Acid Administered Monthly Versus Every 3 Months in Multiple Myeloma and Breast Cancer Patients Who Were Treated With Zoledronic Acid the Prior Year
Novartis
Phase 1 Completed
NCT00582920 2015-12-24
Investigation of Changes in Bone Scan Imaging Before and After Intravenous Bisphosphonate Therapy for Osseous Metastases From Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00742924 2014-07-04
Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma
Children's Oncology Group
Phase 1 Completed
NCT00206388 2013-08-02
Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement
Baylor College of Medicine
Phase 1 Completed
NCT00004928 2013-06-19
Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00741377 2013-02-18
A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients
Novartis
Phase 1 Completed
NCT00415779 2010-02-24
ZANTE
National Cancer Institute, Naples
Phase 1 Completed